June 2024 FDA Recall Drug by Accord Healthcare, Inc.
D-0580-2024 - Subpotent drug

This Class III drug recall was voluntarily initiated by Accord Healthcare, Inc. on June 18, 2024 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0580-2024

Reason for Recall
Subpotent drug: out of specification results
Initiated
06-18-2024
Reported
07-10-2024
Quantity
52,998

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Accord Healthcare, Inc.
Dodex Injectable (Cyanocobalamin Injection) USP, 1,000mcg/mL, 1mL multiple dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad-382 210, India, NDC 16729-533-08, UPC Code: 031672953308

Batch or Lot Expiration Information

Lot# R2200834, R2200835, R2200841, R2200958, Exp 06/30/2024; R2201044 R2201045 R2201046, R2201047, R2201095, R2201142, R2201143, R2201144, Exp 07/31/2024; M2215870, M2215918, Exp 10/2024